Grünelabs

Grüne Labs is a global phythoparmaceutical company with operations in Uruguay and Portugal, leading innovation in therapeutic medicines for children, adults, and veterinary uses through high technology in the processing of botanical specialities. GrüneLabs’ mission is to be a trusted partner for its patients and consumers by transforming their lives with a cultivated experience, health, and wellbeing through high-quality, differentiated, and innovative products. A pioneer in the development of cannabis extraction for drug production, GrüneLabs yields medicinal cannabis to treat neurological diseases and other pathologies. We are focused on transforming biopharmaceutical discoveries into novel medicines to give people around the world to live better, redefining what’s possible. Follow along here to stay up to date on news from our team! For more information, please see our website at www.grunelabs.com.